[1]刘 兵.齐拉西酮与奥氮平治疗早期精神分裂症的疗效[J].医学信息,2020,33(03):136-137.[doi:10.3969/j.issn.1006-1959.2020.03.042]
　LIU Bing.Efficacy of Ziprasidone and Olanzapine in Early Schizophrenia[J].Medical Information,2020,33(03):136-137.[doi:10.3969/j.issn.1006-1959.2020.03.042]
点击复制

齐拉西酮与奥氮平治疗早期精神分裂症的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年03期
页码:
136-137
栏目:
药物与临床
出版日期:
2020-02-01

文章信息/Info

Title:
Efficacy of Ziprasidone and Olanzapine in Early Schizophrenia
文章编号:
1006-1959（2020）03-0136-02
作者:
刘 兵
（合肥市第四人民医院精神科，安徽 合肥 230022）
Author(s):
LIU Bing
(Department of Psychiatry,Hefei Fourth People’s Hospital,Hefei 230022,Anhui,China)
关键词:
齐拉西酮; 奥氮平; 早期精神分裂症; 安全性
Keywords:
Ziprasidone; Olanzapine; Early schizophrenia; Safety
分类号:
R749.3
DOI:
10.3969/j.issn.1006-1959.2020.03.042
文献标志码:
A
摘要:
目的 观察齐拉西酮与奥氮平治疗早期精神分裂症的疗效及安全性。方法 选择2018年1月~2019年1月我院诊治的早期精神分裂症患者98例，采用随机数字表法分为对照组和观察组，各49例。对照组采用奥氮平治疗，观察组采用齐拉西酮，比较两组治疗总有效率、治疗前后PANSS评分及不良反应发生情况。结果 观察组治疗总有效率为93.87%，高于对照组的79.59%，差异有统计学意义（P＜0.05）；治疗后两组阳性症状评分、阴性症状评分、一般病理症状评分、总评分均低于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率为8.16%，低于对照组的20.41%，差异有统计学意义（P＜0.05）。结论 齐拉西酮治疗早期精神分裂症疗效优于奥氮平，有助于缓解临床症状，降低PANSS评分，临床不良反应少，用药安全。
Abstract:
Objective To observe the efficacy and safety of ziprasidone and olanzapine in the treatment of early schizophrenia.Methods A total of 98 patients with early schizophrenia diagnosed and treated in our hospital from January 2018 to January 2019 were selected and randomly divided into a control group and an observation group, with 49 cases in each group. The control group was treated with olanzapine, and the observation group was treated with ziprasidone. The total effective rate, the PANSS score before and after treatment, and the occurrence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 93.87%, which was higher than 79.59% in the control group,the difference was statistically significant (P<0.05). The positive symptom score, negative symptom score, general pathological symptom score, and total score were lower in the two groups after treatment before treatment, and the observation group was lower than the control group, the difference was statistically significant (P<0.05); the incidence of adverse reactions in the observation group was 8.16%, lower than 20.41% of the control group, the difference was statistically significant (P<0.05).Conclusion Ziprasidone is better than olanzapine in the treatment of early schizophrenia. It can help relieve clinical symptoms, reduce PANSS score, have fewer clinical adverse reactions, and be safe to use.

参考文献/References:

[1]李英杰,张秋云.早期精神分裂症应用齐拉西酮与奥氮平治疗的疗效对照分析[J].中国医药科学,2014,8(10):72-73,85. [2]张振明.卡尔加里精神分裂症抑郁量表(中文版)信效度初步分析[J].中国现代药物应用,2014,(24):210-211. [3]段艳平,司天梅,苏允爱,等.奥氮平换用齐拉西酮治疗精神分裂症的安全性和有效性研究[J].精神医学杂志,2014,２６(1)：5-8. [4]朱丽荣.齐拉西酮与利培酮治疗女性精神分裂症患者疗效对比分析[J].中国药物与临床,2015,15(11):1610-1612. [5]赵元玲.齐拉西酮与奥氮平治疗女性早期精神分裂症疗效比较[J].临床医药文献电子杂志,2015,2(26):5530-5530.

相似文献/References:

[1]鲁从林,王先丹,杨遂平,等.奥氮平治疗老年痴呆伴精神行为障碍的临床疗效观察[J].医学信息,2018,31(01):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
　LU Cong-lin,WANG Xian-dan,YANG Sui-ping,et al.The Clinical Efficacy of Olanzapine in the Treatment of Alzheimer's Disease with Mental Behavior Disorder[J].Medical Information,2018,31(03):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
[2]蔡 枫,姚雪阳.利培酮与奥氮平治疗酒精所致精神和行为障碍的临床研究[J].医学信息,2018,31(03):137.[doi:10.3969/j.issn.1006-1959.2018.03.048]
　CAI Feng,YAO Xue-yang.Clinical Study of Risperidone and Olanzapine in the Treatment of Alcohol-induced Mental and Behavioral Disorders[J].Medical Information,2018,31(03):137.[doi:10.3969/j.issn.1006-1959.2018.03.048]
[3]黄美英,符 奇.奥氮平与阿立哌唑治疗首发精神分裂症的效果及其对患者认知功能的影响[J].医学信息,2020,33(21):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
　HUANG Mei-ying,FU Qi.The Effect of Olanzapine and Aripiprazole in the Treatment of First-episode Schizophrenia and Its Influence on Patients’ Cognitive Function[J].Medical Information,2020,33(03):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
[4]吴 鹏.坦度螺酮联合奥氮平对精神分裂症患者认知功能的影响[J].医学信息,2021,34(16):9.[doi:10.3969/j.issn.1006-1959.2021.16.003]
　WU Peng.The Effect of Tandospirone Combined with Olanzapine on the Cognitive Function of Patients with Schizophrenia[J].Medical Information,2021,34(03):9.[doi:10.3969/j.issn.1006-1959.2021.16.003]
[5]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
　SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Medical Information,2018,31(03):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]

更新日期/Last Update: 2020-02-01